You are here: vision-research.eu » News » Newsdetails:

Hidden conflicts?

Pharma payments to FDA advisers after drug approvals spark ethical concerns

Apparent conflicts may have also slipped by: Science found that at the time of or in the year leading up to the advisory meetings, many of those panel members—including Halperin—received payments or other financial support from the drugmaker or key competitors for consulting, travel, lectures, or research. FDA did not publicly note those financial ties.